Intranasal midazolam as first‐line inhospital treatment for status epilepticus: a pharmaco‐EEG cohort study

OBJECTIVE: We sought to evaluate the efficacy and tolerability of intranasal midazolam (in‐MDZ) as first‐line inhospital therapy in patients with status epilepticus (SE) during continuous EEG recording. METHODS: Data on medical history, etiology and semiology of SE, anticonvulsive medication usage,...

Descripción completa

Detalles Bibliográficos
Autores principales: Kay, Lara, Merkel, Nina, von Blomberg, Anemone, Willems, Laurent M., Bauer, Sebastian, Reif, Philipp S., Schubert‐Bast, Susanne, Rosenow, Felix, Strzelczyk, Adam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917318/
https://www.ncbi.nlm.nih.gov/pubmed/31682078
http://dx.doi.org/10.1002/acn3.50932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6917318/
https://www.ncbi.nlm.nih.gov/pubmed/31682078
http://dx.doi.org/10.1002/acn3.50932

Ejemplares similares